Funded Project Details - FY2021
|Title:|| Interleukin-33 as an immune therapy for stroke|
|Congressional District Code:
||Biomedical Laboratory R&D
|| October 2018 -
|FY 2021 Funding Amount:
|Total Award Amount
View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER
Stroke is one of the major medical concerns for United States military veterans. The classically neurocentric view of the brain in stroke research may have hindered the development of effective therapies. White matter (WM) injury, characterized by loss of myelin and myelin-producing oligodendrocytes (OLs), is a major cause of functional disability after stroke but has not been widely appreciated until recently. Strategies that are able to alleviate both gray matter and WM pathophysiology are nee...
Questions about the R&D website? Email the Web Team
Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.